首页> Clinical cancer research : an official journal of the American Association for Cancer Research> Targeting PLK1 Reduces MMP10 to Enhance Radiosensitivity in HPV- Head and Neck Cancer.

Targeting PLK1 Reduces MMP10 to Enhance Radiosensitivity in HPV- Head and Neck Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Julianna,Korns

第一单位： Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio.

作者： Julianna,Korns ^[1] ; Maria A,Lehn ^[2] ; Shreya,Shyamsunder ^[1] ; Mario,Medvedovic ^[3] ; Stephanie M,Bryant ^[4] ; Mathieu G,Sertorio ^[1] ; Maya,Ridinger ^[5] ; Trisha M,Wise-Draper ^[6] ; Vinita,Takiar ^[7]

作者单位： Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio. ^[1] Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio.;Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio. ^[2] Center for Biostatistics and Bioinformatics Services, University of Cincinnati, Cincinnati, Ohio.;Department of Biostatistics, Health Informatics and Data Science, University of Cincinnati, Cincinnati, Ohio. ^[3] Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio. ^[4] Cardiff Oncology, San Diego, California. ^[5] Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio. ^[6] Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio.;Research Service, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio. ^[7]